Bellicum To Report Second Quarter 2016 Financial Results And Host Conference Call And Webcast On August 8, 2016

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the Company will host a conference call and live webcast on Monday, August 8, 2016 at 5:00 p.m. EDT to report its second quarter 2016 financial results and provide a corporate update.